News Releases - Achieve Life Sciences

News Releases

Home

Home ivps4 2017-06-16T21:39:52+00:00

News Releases

Investor Alerts

Jan 7, 2021

Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference
Dec 7, 2020

Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
Dec 3, 2020

Achieve Life Sciences Announces Pricing of $15 Million Public Offering
Nov 30, 2020

Achieve Life Sciences Announces Proposed Public Offering
Nov 12, 2020

Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
Oct 29, 2020

Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020
Oct 27, 2020

Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020
Oct 22, 2020

Achieve Life Sciences Shareholder Letter - October 2020
Oct 8, 2020

Achieve Life Sciences to Present at the MicroCap Best Ideas Conference, October 13, 2020
Oct 7, 2020

Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation

Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo

Show per page

Stock Info